Candel Therapeutics (CADL) Interest & Investment Income (2020 - 2023)
Historic Interest & Investment Income for Candel Therapeutics (CADL) over the last 4 years, with Q4 2023 value amounting to $415000.0.
- Candel Therapeutics' Interest & Investment Income fell 4838.31% to $415000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.1 million, marking a year-over-year increase of 9971.21%. This contributed to the annual value of $1.1 million for FY2024, which is 4781.36% down from last year.
- Latest data reveals that Candel Therapeutics reported Interest & Investment Income of $415000.0 as of Q4 2023, which was down 4838.31% from $502000.0 recorded in Q3 2023.
- Candel Therapeutics' 5-year Interest & Investment Income high stood at $804000.0 for Q4 2022, and its period low was -$175000.0 during Q1 2022.
- In the last 4 years, Candel Therapeutics' Interest & Investment Income had a median value of $70000.0 in 2022 and averaged $217000.0.
- Data for Candel Therapeutics' Interest & Investment Income shows a peak YoY increase of 740909.09% (in 2022) and a maximum YoY decrease of 135833.33% (in 2022) over the last 5 years.
- Candel Therapeutics' Interest & Investment Income (Quarter) stood at $49000.0 in 2020, then plummeted by 122.45% to -$11000.0 in 2021, then soared by 7409.09% to $804000.0 in 2022, then crashed by 48.38% to $415000.0 in 2023.
- Its Interest & Investment Income was $415000.0 in Q4 2023, compared to $502000.0 in Q3 2023 and $453000.0 in Q2 2023.